Immune-mediated mechanisms of atherosclerosis and implications for the clinic. (2016)
Attributed to:
Low dose interleukin (IL)-2 in patients with a recent acute coronary syndrome
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1080/1744666x.2016.1195686
PubMed Identifier: 27253721
Publication URI: http://europepmc.org/abstract/MED/27253721
Type: Journal Article/Review
Volume: 12
Parent Publication: Expert review of clinical immunology
Issue: 11
ISSN: 1744-666X